These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21161615)

  • 81. BLyS-mediated modulation of naive B cell subsets impacts HIV Env-induced antibody responses.
    Dosenovic P; Soldemo M; Scholz JL; O'Dell S; Grasset EK; Pelletier N; Karlsson MC; Mascola JR; Wyatt RT; Cancro MP; Karlsson Hedestam GB
    J Immunol; 2012 Jun; 188(12):6018-26. PubMed ID: 22561155
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Studying the Immune Synapse in HIV-1 Infection.
    Del Río-Iñiguez I; Bouchet J; Alcover A
    Methods Mol Biol; 2017; 1584():545-557. PubMed ID: 28255725
    [TBL] [Abstract][Full Text] [Related]  

  • 84. T-cell immune responses against Env from CRF12_BF and subtype B HIV-1 show high clade-specificity that can be overridden by multiclade immunizations.
    Mónaco DC; Rodríguez AM; Pascutti MF; Carobene M; Falivene J; Gómez A; Maeto C; Turk G; Nájera JL; Esteban M; Gherardi MM
    PLoS One; 2011 Feb; 6(2):e17185. PubMed ID: 21364754
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization.
    Tobery TW; Siliciano RF
    J Exp Med; 1997 Mar; 185(5):909-20. PubMed ID: 9120397
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction.
    Brocca-Cofano E; Kuhrt D; Siewe B; Xu C; Haret-Richter GS; Craigo J; Labranche C; Montefiori DC; Landay A; Apetrei C; Pandrea I
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931679
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines.
    Excler JL; Ake J; Robb ML; Kim JH; Plotkin SA
    Clin Vaccine Immunol; 2014 Aug; 21(8):1023-36. PubMed ID: 24920599
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
    Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
    J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).
    Rosales-Mendoza S; Rubio-Infante N; Govea-Alonso DO; Moreno-Fierros L
    Plant Cell Rep; 2012 Mar; 31(3):495-511. PubMed ID: 22159962
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation.
    Martinez P; Sundling C; O'Dell S; Mascola JR; Wyatt RT; Karlsson Hedestam GB
    Sci Rep; 2015 Mar; 5():8925. PubMed ID: 25762407
    [TBL] [Abstract][Full Text] [Related]  

  • 92. IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine.
    Sarkar S; Piepenbrink MS; Basu M; Thakar J; Keefer MC; Hessell AJ; Haigwood NL; Kobie JJ
    Vaccine; 2019 Apr; 37(17):2322-2330. PubMed ID: 30926296
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Criteria for selection of HIV vaccine candidates--general principles.
    Ensoli B
    Microbes Infect; 2005 Nov; 7(14):1433-5. PubMed ID: 16213181
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
    Kibler KV; Asbach B; Perdiguero B; García-Arriaza J; Yates NL; Parks R; Stanfield-Oakley S; Ferrari G; Montefiori DC; Tomaras GD; Roederer M; Foulds KE; Forthal DN; Seaman MS; Self S; Gottardo R; Phogat S; Tartaglia J; Barnett S; Cristillo AD; Weiss D; Galmin L; Ding S; Heeney JL; Esteban M; Wagner R; Pantaleo G; Jacobs BL
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429340
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Determinants in HIV-1 Nef for enhancement of virus replication and depletion of CD4+ T lymphocytes in human lymphoid tissue ex vivo.
    Homann S; Tibroni N; Baumann I; Sertel S; Keppler OT; Fackler OT
    Retrovirology; 2009 Jan; 6():6. PubMed ID: 19146681
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines.
    Elsayed H; Nabi G; McKinstry WJ; Khoo KK; Mak J; Salazar AM; Tenbusch M; Temchura V; Überla K
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743369
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Short communication: HIV-1 Nef protein carries multiple epitopes suitable for induction of cellular immunity for an HIV vaccine in Africa.
    Kilpeläinen A; Axelsson Robertson R; Leitner T; Sandström E; Maeurer M; Wahren B
    AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1065-71. PubMed ID: 24866397
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Neutrophil Vaccination Dynamics and Their Capacity To Mediate B Cell Help in Rhesus Macaques.
    Musich T; Rahman MA; Mohanram V; Miller-Novak L; Demberg T; Venzon DJ; Felber BK; Franchini G; Pavlakis GN; Robert-Guroff M
    J Immunol; 2018 Oct; 201(8):2287-2302. PubMed ID: 30217830
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Differential impact of magnitude, polyfunctional capacity, and specificity of HIV-specific CD8+ T cell responses on HIV set point.
    Riou C; Burgers WA; Mlisana K; Koup RA; Roederer M; Abdool Karim SS; Williamson C; Gray CM
    J Virol; 2014 Feb; 88(3):1819-24. PubMed ID: 24227857
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
    Tomiyama H; Akari H; Adachi A; Takiguchi M
    J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.